Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

483 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells.
Amaro A, Reggiani F, Fenoglio D, Gangemi R, Tosi A, Parodi A, Banelli B, Rigo V, Mastracci L, Grillo F, Cereghetti A, Tastanova A, Ghosh A, Sallustio F, Emionite L, Daga A, Altosole T, Filaci G, Rosato A, Levesque M, Maio M, Pfeffer U, Croce M; EPigenetic Immune-oncology Consortium Airc (EPICA) consortium. Amaro A, et al. Among authors: rosato a. J Exp Clin Cancer Res. 2023 Mar 18;42(1):67. doi: 10.1186/s13046-023-02628-x. J Exp Clin Cancer Res. 2023. PMID: 36934257 Free PMC article.
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab.
Narducci MG, Tosi A, Frezzolini A, Scala E, Passarelli F, Bonmassar L, Monopoli A, Accetturi MP, Cantonetti M, Antonini Cappellini GC, De Galitiis F, Rosato A, Picozza M, Russo G, D'Atri S. Narducci MG, et al. Among authors: rosato a. Front Immunol. 2020 Sep 25;11:579894. doi: 10.3389/fimmu.2020.579894. eCollection 2020. Front Immunol. 2020. PMID: 33072126 Free PMC article. Clinical Trial.
The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
Tosi A, Cappellesso R, Dei Tos AP, Rossi V, Aliberti C, Pigozzo J, Fabozzi A, Sbaraglia M, Blandamura S, Del Bianco P, Chiarion-Sileni V, Rosato A. Tosi A, et al. Among authors: rosato a. J Exp Clin Cancer Res. 2021 May 4;40(1):154. doi: 10.1186/s13046-021-01947-1. J Exp Clin Cancer Res. 2021. PMID: 33947438 Free PMC article.
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial.
Dieci MV, Guarneri V, Tosi A, Bisagni G, Musolino A, Spazzapan S, Moretti G, Vernaci GM, Griguolo G, Giarratano T, Urso L, Schiavi F, Pinato C, Magni G, Lo Mele M, De Salvo GL, Rosato A, Conte P. Dieci MV, et al. Among authors: rosato a. Clin Cancer Res. 2022 Jan 15;28(2):308-317. doi: 10.1158/1078-0432.CCR-21-2260. Epub 2021 Oct 19. Clin Cancer Res. 2022. PMID: 34667023 Free PMC article.
Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma.
Tosi A, Nardinocchi L, Carbone ML, Capriotti L, Pagani E, Mastroeni S, Fortes C, Scopelliti F, Cattani C, Passarelli F, Rosato A, D'Atri S, Failla CM, Cavani A. Tosi A, et al. Among authors: rosato a. Biomedicines. 2021 Dec 16;9(12):1930. doi: 10.3390/biomedicines9121930. Biomedicines. 2021. PMID: 34944746 Free PMC article.
483 results